doi:10.16138/j.1673-6087.2021.03.015

Abstract

CLC Number:

References 31

[1]	Salazar J, Luzardo E, Mejías JC, et al. Epicardial fat: physiological, pathological, and therapeutic implications[J]. Cardiol Res Pract, 2016, 2016: 1291537.
[2]	Neeland IJ, Ross R, Després JP, et al. Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement[J]. Lancet Diabetes Endocrinol, 2019, 7(9): 715-725. doi: 10.1016/S2213-8587(19)30084-1 URL
[3]	Villasante Fricke AC, Iacobellis G. Epicardial adipose tissue: clinical biomarker of cardio-metabolic risk[J]. Int J Mol Sci, 2019, 20(23): 5989. doi: 10.3390/ijms20235989 URL
[4]	Iacobellis G, Assael F, Ribaudo MC, et al. Epicardial fat from echocardiography: a new method for visceral adipose tissue prediction[J]. Obes Res, 2003, 11(2): 304-310. pmid: 12582228
[5]	Rabkin SW. The relationship between epicardial fat and indices of obesity and the metabolic syndrome: a systematic review and meta-analysis[J]. Metab Syndr Relat Disord, 2014, 12(1): 31-42. doi: 10.1089/met.2013.0107 URL
[6]	Ansari MA, Mohebati M, Poursadegh F, et al. Is echocardiographic epicardial fat thickness increased in patients with coronary artery disease? A systematic review and meta-analysis[J]. Electron Physician, 2018, 10(9): 7249-7258. doi: 10.19082/7249 URL
[7]	Bachar GN, Dicker D, Kornowski R, et al. Epicardial adipose tissue as a predictor of coronary artery disease in asymptomatic subjects[J]. Am J Cardiol, 2012, 110(4): 534-538. doi: 10.1016/j.amjcard.2012.04.024 pmid: 22579086
[8]	Toya T, Corban MT, Imamura K, et al. Coronary perivascular epicardial adipose tissue and major adverse cardiovascular events after ST segment-elevation myocardial infarction[J]. Atherosclerosis, 2020, 302: 27-35. doi: 10.1016/j.atherosclerosis.2020.04.012 URL
[9]	Al Chekakie MO, Welles CC, Metoyer R, et al. Pericardial fat is independently associated with human atrial fibrillation[J]. J Am Coll Cardiol, 2010, 56(10): 784-788. doi: 10.1016/j.jacc.2010.03.071 pmid: 20797492
[10]	Gaeta M, Bandera F, Tassinari F, et al. Is epicardial fat depot associated with atrial fibrillation[J]?. Europace, 2017, 19(5): 747-752. doi: 10.1093/europace/euw398 URL
[11]	Sepehri Shamloo A, Dagres N, Dinov B, et al. Is epicardial fat tissue associated with atrial fibrillation recurrence after ablation[J]?. Int J Cardiol Heart Vasc, 2019, 22: 132-138.
[12]	Erdogan G, Belen E, Sungur MA, et al. Assessment of epicardial adipose tissue thickness in patients with resistant hypertension[J]. Blood Press Monit, 2016, 21(1): 16-20. doi: 10.1097/MBP.0000000000000149 pmid: 26317386
[13]	Song Y, Song F, Wu C, et al. The roles of epicardial adipose tissue in heart failure[J]. Heart Fail Rev, 2020. [Epub ahead of print].
[14]	Koepp KE, Obokata M, Reddy YNV, et al. Hemodynamic and functional impact of epicardial adipose tissue in heart failure with preserved ejection fraction[J]. JACC Heart Fail, 2020, 8(8): 657-666. doi: 10.1016/j.jchf.2020.04.016 URL
[15]	van Woerden G, Gorter TM, Westenbrink BD, et al. Epicardial fat in heart failure patients with mid-range and preserved ejection fraction[J]. Eur J Heart Fail, 2018, 20(11): 1559-1566. doi: 10.1002/ejhf.1283 pmid: 30070041
[16]	Li Y, Liu B, Li Y, et al. Epicardial fat tissue in patients with diabetes mellitus: a systematic review and meta-analysis[J]. Cardiovasc Diabetol, 2019, 18(1): 3. doi: 10.1186/s12933-019-0807-3 URL
[17]	Iacobellis G, Bianco AC. Epicardial adipose tissue: emerging physiological, pathophysiological and clinical features[J]. Trends Endocrinol Metab, 2011, 22(11): 450-457. doi: 10.1016/j.tem.2011.07.003 URL
[18]	Sayin I, Erkan AF, Ekici B, et al. Thickening of the epicardial adipose tissue can be alleviated by thyroid hormone replacement therapy in patients with subclinical hypothyroidism[J]. Kardiol Pol, 2016, 74(12): 1492-1498. doi: 10.5603/KP.a2016.0053 URL
[19]	王怡文, 王侃侃, 宋玉玲, 等. 亚临床甲状腺功能减退症与心外膜脂肪组织厚度相关性的Meta分析[J]. 滨州医学院学报, 2019, 42(3): 188-212.
[20]	Altunbaş R, Eren MA, Altıparmak IH, et al. The relation between epicardial fat tissue thickness and TSH receptor antibody in hyperthyroidism[J]. Exp Clin Endocrinol Diabetes, 2019, 127(1): 37-40.
[21]	Liu B, Li Y, Li Y, et al. Association of epicardial adipose tissue with non-alcoholic fatty liver disease: a meta-analysis[J]. Hepatol Int, 2019, 13(6): 757-765. doi: 10.1007/s12072-019-09972-1 URL
[22]	Meng X, Wang W, Zhang K, et al. Epicardial adipose tissue volume is associated with non-alcoholic fatty liver disease and cardiovascular risk factors in the general population[J]. Ther Clin Risk Manag, 2018, 14: 1499-1506. doi: 10.2147/TCRM.S168345 URL
[23]	Lin A, Wong ND, Razipour A, et al. Metabolic syndrome, fatty liver, and artificial intelligence-based epicardial adipose tissue measures predict long-term risk of cardiac events: a prospective study[J]. Cardiovasc Diabetol, 2021, 20(1): 27. doi: 10.1186/s12933-021-01220-x URL
[24]	Chacińska M, Zabielski P, Ksiazek M, et al. The impact of OMEGA-3 fatty acids supplementation on insulin resistance and content of adipocytokines and biologically active lipids in adipose tissue of high-fat diet fed rats[J]. Nutrients, 2019, 11(4): 835. doi: 10.3390/nu11040835 URL
[25]	Ziyrek M, Kahraman S, Ozdemir E, et al. Metformin monotherapy significantly decreases epicardial adipose tissue thickness in newly diagnosed type 2 diabetes patients[J]. Rev Port Cardiol, 2019, 38(6): 419-423. doi: 10.1016/j.repc.2018.08.010 URL
[26]	Grosso AF, de Oliveira SF, Higuchi Mde L, et al. Synergistic anti-inflammatory effect: simvastatin and pioglitazone reduce inflammatory markers of plasma and epicardial adipose tissue of coronary patients with metabolic syndrome[J]. Diabetol Metab Syndr, 2014, 6(1): 47. doi: 10.1186/1758-5996-6-47 URL
[27]	Iacobellis G, Mohseni M, Bianco SD, et al. Liraglutide causes large and rapid epicardial fat reduction[J]. Obesity (Silver Spring), 2017, 25(2): 311-316. doi: 10.1002/oby.21718 URL
[28]	Bizino MB, Jazet IM, de Heer P, et al. Placebo-controlled randomised trial with liraglutide on magnetic resonance endpoints in individuals with type 2 diabetes: a pre-specified secondary study on ectopic fat accumulation[J]. Diabetologia, 2020, 63(1): 65-74. doi: 10.1007/s00125-019-05021-6 URL
[29]	Braha A, Timar B, Diaconu L, et al. Dynamics of epicardiac fat and heart function in type 2 diabetic patients initiated with SGLT-2 inhibitors[J]. Diabetes Metab Syndr Obes, 2019, 12: 2559-2566. doi: 10.2147/DMSO.S223629 URL
[30]	Parisi V, Petraglia L, D'Esposito V, et al. Statin therapy modulates thickness and inflammatory profile of human epicardial adipose tissue[J]. Int J Cardiol, 2019, 274: 326-330. doi: 10.1016/j.ijcard.2018.06.106 URL
[31]	Launbo N, Zobel EH, von Scholten BJ, et al. Targeting epicardial adipose tissue with exercise, diet, bariatric surgery or pharmaceutical interventions[J]. Obes Rev, 2021, 22(1): e13136.

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 31

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	WU Liqun. Greatness in simplicity—new technology of pulmonary vein isolation [J]. Journal of Internal Medicine Concepts & Practice, 2022, 17(05): 357-359.
[2]	LI Ruogu. Clinical application of His bundle pacing [J]. Journal of Internal Medicine Concepts & Practice, 2022, 17(05): 360-364.
[3]	TANG Baopeng, ZHANG Jianghua, GUO Yankai. Progress in clinical application of leadless pacemaker [J]. Journal of Internal Medicine Concepts & Practice, 2022, 17(05): 365-368.
[4]	LIU Ruifeng, SHENG Qianqian, ZHANG Yue, ZHAO Huiqiang. Lymphocyte and monocyte subtypes in coronary artery ectasia patients [J]. Journal of Internal Medicine Concepts & Practice, 2022, 17(05): 373-378.
[5]	YIN Xiang, ZHENG Liangrong. Research progress of percutaneous left atrial appendage occlusion for stroke prevention in atrial fibrillation [J]. Journal of Internal Medicine Concepts & Practice, 2022, 17(05): 392-395.
[6]	FEI Zhentao, CHEN Mu, LI Yigang. Research progress on mechanism of atrial fibrillation recurrence after catheter ablation [J]. Journal of Internal Medicine Concepts & Practice, 2022, 17(05): 396-399.
[7]	ZHANG Zhi, TANG Xuechao, HUANG Xinmiao, et al. Application of pulsed electric field ablation in atrial fibrillation [J]. Journal of Internal Medicine Concepts & Practice, 2022, 17(05): 400-404.
[8]	YANG Ling, ZHA Qing, ZHANG Qianru, YE Jiawen, YANG Ke, LIU Yan. Biomarker-based predictive model for calcific aortic valve disease [J]. Journal of Internal Medicine Concepts & Practice, 2022, 17(04): 324-329.
[9]	. [J]. Journal of Internal Medicine Concepts & Practice, 2022, 17(04): 337-338.
[10]	LI Xinni, MA Wenkun, GAO Chengjie, GAO Yajie, JIN Xuejuan, ZHOU Yi, SHEN Chengxing, PAN Jingwei. Influence of different diagnostic criteria on the prevalence of hypertension in the population [J]. Journal of Internal Medicine Concepts & Practice, 2022, 17(04): 273-277.
[11]	GAO Jian, WANG Deqin, ZHOU Yonghua, MIAO Xianjing, CHEN Yu, JING Xin, WANG Yan. Study on relationship between serum growth stimulation expressed gene 2 and lipoprotein-associated phospholipase 2 and cardiovascular events in maintenance hemodialysis patients [J]. Journal of Internal Medicine Concepts & Practice, 2022, 17(04): 295-300.
[12]	XI Rui, FAN Qin, WANG Fang, TAO Rong, GU Gang. Value of D-dimer combined with cystatin C in predicting the occurrence of major adverse cardiovascular events in patients with acute myocardial infarction undergoing percutaneous coronary intervention [J]. Journal of Internal Medicine Concepts & Practice, 2022, 17(03): 227-232.
[13]	HU Jian, YANG Zhenkun, YAN Xiaoxiang, DU Run, DING Fenghua, LIU Jun. Comparison of the efficacy of percutaneous coronary intervention and coronary artery bypass grafting in octogenarian with chronic total occlusion of left anterior descending artery [J]. Journal of Internal Medicine Concepts & Practice, 2022, 17(01): 70-72.
[14]	. [J]. Journal of Internal Medicine Concepts & Practice, 2021, 16(05): 366-370.
[15]	WANG Shun, ZHU Huafang, MAO Chengyu, LI Dongjiu, WANG Changqian. Experimental study of the effect of compound combination of traditional Chinese medicine on atherosclerosis [J]. Journal of Internal Medicine Concepts & Practice, 2021, 16(04): 261-266.